X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (378) 378
Conference Proceeding (36) 36
Publication (25) 25
Book Review (9) 9
Book Chapter (2) 2
Book / eBook (1) 1
Video Recording (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
medical and health sciences (257) 257
medicin och hälsovetenskap (257) 257
hematology (178) 178
humans (174) 174
index medicus (171) 171
clinical medicine (169) 169
klinisk medicin (169) 169
hematologi (114) 114
male (105) 105
female (101) 101
middle aged (100) 100
aged (82) 82
adult (73) 73
cancer and oncology (67) 67
cancer och onkologi (67) 67
medicine (67) 67
medicin (65) 65
oncology (61) 61
prognosis (45) 45
abridged index medicus (38) 38
chronic lymphocytic leukemia (37) 37
leukemia, lymphocytic, chronic, b-cell - genetics (37) 37
survival (37) 37
treatment outcome (34) 34
aged, 80 and over (31) 31
cancer (26) 26
basic medicine (25) 25
medicinska och farmaceutiska grundvetenskaper (25) 25
cladribine (24) 24
leukemia (23) 23
transplantation (22) 22
remission induction (20) 20
survival analysis (20) 20
survival rate (20) 20
antineoplastic agents - therapeutic use (19) 19
leukemia, lymphocytic, chronic, b-cell - drug therapy (18) 18
leukemia, lymphocytic, chronic, b-cell - mortality (17) 17
risk factors (17) 17
2-chlorodeoxyadenosine (16) 16
cladribine - therapeutic use (16) 16
cll (16) 16
risk (16) 16
antineoplastic combined chemotherapy protocols - therapeutic use (15) 15
chromosome aberrations (15) 15
follow-up studies (15) 15
genetics & heredity (15) 15
karyotyping (15) 15
multiple myeloma (15) 15
cell and molecular biology (14) 14
cell- och molekylärbiologi (14) 14
expression (14) 14
therapy (14) 14
adolescent (13) 13
chronic lymphocytic-leukemia (13) 13
hemic and lymphatic diseases (13) 13
medical genetics (13) 13
medicinsk genetik (13) 13
young adult (13) 13
kaplan-meier estimate (12) 12
leukemia, hairy cell - drug therapy (12) 12
mutation (12) 12
registries (12) 12
research (12) 12
sweden (12) 12
age (11) 11
analysis (11) 11
chronic lymphocytic leukaemia (11) 11
health aspects (11) 11
immunoglobulin heavy chains - genetics (11) 11
pharmacokinetics (11) 11
stem cells (11) 11
2-chloro-2'-deoxyadenosine (10) 10
acute myeloid-leukemia (10) 10
age factors (10) 10
cladribine - administration & dosage (10) 10
disease progression (10) 10
leukemia, myeloid, acute - drug therapy (10) 10
retrospective studies (10) 10
acute myeloid leukemia (9) 9
aml (9) 9
care and treatment (9) 9
chemotherapy (9) 9
disease-free survival (9) 9
genetic aspects (9) 9
immunology (9) 9
leukemia, myeloid, acute - mortality (9) 9
medicine, general & internal (9) 9
multiple myeloma - drug therapy (9) 9
population based (9) 9
sweden - epidemiology (9) 9
toxicity (9) 9
transplantation, homologous (9) 9
antineoplastic agents - administration & dosage (8) 8
chromosomes, human, pair 12 (8) 8
dose-response relationship, drug (8) 8
gene (8) 8
gene expression (8) 8
genomic aberrations (8) 8
hematology, oncology and palliative medicine (8) 8
incidence (8) 8
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


NEW ENGLAND JOURNAL OF MEDICINE, ISSN 0028-4793, 07/2013, Volume 369, Issue 1, pp. 95 - 96
Journal Article
Cytometry Part B: Clinical Cytometry, ISSN 1552-4949, 03/2018, Volume 94, Issue 2, pp. 264 - 269
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 10/2012, Volume 30, Issue 29, pp. 3633 - 3639
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 09/2009, Volume 27, Issue 26, pp. 4378 - 4384
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2010, Volume 11, Issue 10, pp. 973 - 982
Summary Background Compared with placebo, prophylactic treatment with bisphosphonates reduces risk of skeletal events in patients with multiple myeloma.... 
Hematology, Oncology and Palliative Medicine | SURVIVAL | BISPHOSPHONATES | MULTICENTER | EFFICACY | ONCOLOGY | CLODRONATE | QUALITY-OF-LIFE | STEM-CELL TRANSPLANTATION | DKK1 | CHEMOTHERAPY | BONE-RESORPTION | Multiple Myeloma - mortality | Humans | Middle Aged | Male | Transplantation, Autologous | Jaw Diseases - chemically induced | Stem Cell Transplantation | Bone Diseases - etiology | Multiple Myeloma - therapy | Time Factors | Aged, 80 and over | Female | Diphosphonates - adverse effects | Bone Density Conservation Agents - adverse effects | Double-Blind Method | Multiple Myeloma - diagnosis | Risk Assessment | Multiple Myeloma - complications | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Bone Diseases - prevention & control | Treatment Outcome | Diphosphonates - administration & dosage | Bone Density Conservation Agents - administration & dosage | Bone Diseases - diagnostic imaging | Scandinavian and Nordic Countries | Radiography | Bone Diseases - mortality | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Quality of Life | Aged | Infusions, Intravenous | Osteonecrosis - chemically induced | Medicine, Experimental | Clinical trials | Medical research | Care and treatment | Multiple myeloma | Index Medicus | Medical and Health Sciences | MEDICINE | Medicin och hälsovetenskap | MEDICIN
Journal Article
Nature Genetics, ISSN 1061-4036, 01/2014, Volume 46, Issue 1, pp. 56 - 60
Journal Article
PLoS ONE, ISSN 1932-6203, 02/2017, Volume 12, Issue 2, pp. e0171205 - e0171205
Background Smoldering multiple myeloma (SMM) is an indolent disease stage, considered to represent the transition phase from the premalignant MGUS (Monoclonal... 
RHEUMATOID-ARTHRITIS | ZOLEDRONIC ACID | CRITERIA | DIAGNOSIS | MULTIDISCIPLINARY SCIENCES | INDOLENT MYELOMA | ICAM-1 | DRUG-RESISTANCE | STAGE-I | THALIDOMIDE | PROGRESSION | Monoclonal Gammopathy of Undetermined Significance - drug therapy | Intercellular Adhesion Molecule-1 - immunology | Humans | Middle Aged | Monoclonal Gammopathy of Undetermined Significance - diagnosis | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - pharmacokinetics | Antibodies, Monoclonal - therapeutic use | Male | Treatment Outcome | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Intercellular Adhesion Molecule-1 - metabolism | Antibodies, Monoclonal - administration & dosage | Antineoplastic Agents - adverse effects | Biomarkers | Female | Aged | Antineoplastic Agents - pharmacokinetics | Leukocyte Count | Care and treatment | Analysis | Multiple myeloma | Monoclonal antibodies | Clinical trials | Development and progression | Research | Health aspects | Adhesion tests | Medical services | Oncology | Gammopathy | Proteins | Immunology | Cell adhesion | Smoldering | Bone marrow | Rheumatism | Safety | Drug dosages | Stroke | Pharmacodynamics | Immunoglobulins | Cytokines | Phase transformations | Hematology | Intercellular adhesion molecule 1 | Tumor cells | Medical treatment | Monoclonal gammopathy | Pharmacology | Patients | Adhesion | Side effects | Rheumatoid arthritis | Lymphomas | Index Medicus | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Cancer and Oncology | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article
Journal Article
Genes, Chromosomes and Cancer, ISSN 1045-2257, 10/2016, Volume 55, Issue 10, pp. 750 - 766
Journal Article
Nature Genetics, ISSN 1061-4036, 02/2010, Volume 42, Issue 2, pp. 132 - 136
Journal Article
Journal Article
American Journal of Hematology, ISSN 0361-8609, 03/2015, Volume 90, Issue 3, pp. 208 - 214
Journal Article